These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 36906872)

  • 1. Epigenetic perspectives associated with COVID-19 infection and related cytokine storm: an updated review.
    Dey A; Vaishak K; Deka D; Radhakrishnan AK; Paul S; Shanmugam P; Daniel AP; Pathak S; Duttaroy AK; Banerjee A
    Infection; 2023 Dec; 51(6):1603-1618. PubMed ID: 36906872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of epigenetics in affecting host immunity during SARS-CoV-2 infection.
    Behura A; Naik L; Patel S; Das M; Kumar A; Mishra A; Nayak DK; Manna D; Mishra A; Dhiman R
    Biochim Biophys Acta Mol Basis Dis; 2023 Mar; 1869(3):166634. PubMed ID: 36577469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and epigenetic factors associated with increased severity of Covid-19.
    Yildirim Z; Sahin OS; Yazar S; Bozok Cetintas V
    Cell Biol Int; 2021 Jun; 45(6):1158-1174. PubMed ID: 33590936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19.
    Zhang X; Zhang Y; Qiao W; Zhang J; Qi Z
    Int Immunopharmacol; 2020 Sep; 86():106749. PubMed ID: 32645632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potential of green tea catechin, (-)-epigallocatechin-3-
    Dinda B; Dinda S; Dinda M
    Phytomed Plus; 2023 Feb; 3(1):100402. PubMed ID: 36597465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of host epigenome by coronavirus infections and developing treatment modalities for COVID-19 beyond genetics.
    Rabaan AA; Al Mutair A; Alhumaid S; Al Alawi Z; Al Mohaini M; Alsalman AJ; Fawzy M; Al-Tawfiq JA; Almahmoud S; Alfouzan W; Bilal M; Dhawan M; Mohapatra RK; Tiwari R; Khan Z; Mitra S; Emran TB; Dhama K
    Eur Rev Med Pharmacol Sci; 2021 Oct; 25(19):5947-5964. PubMed ID: 34661254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic mechanisms influencing COVID-19.
    Sen R; Garbati M; Bryant K; Lu Y
    Genome; 2021 Apr; 64(4):372-385. PubMed ID: 33395363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients.
    Sawalha AH; Zhao M; Coit P; Lu Q
    Clin Immunol; 2020 Jun; 215():108410. PubMed ID: 32276140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual mechanism: Epigenetic inhibitor apabetalone reduces SARS-CoV-2 Delta and Omicron variant spike binding and attenuates SARS-CoV-2 RNA induced inflammation.
    Fu L; Gilham D; Stotz SC; Sarsons CD; Rakai BD; Tsujikawa LM; Wasiak S; Johansson JO; Sweeney M; Wong NCW; Kulikowski E
    Int Immunopharmacol; 2023 Apr; 117():109929. PubMed ID: 36857935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 Is a Multi-Organ Aggressor: Epigenetic and Clinical Marks.
    Kgatle MM; Lawal IO; Mashabela G; Boshomane TMG; Koatale PC; Mahasha PW; Ndlovu H; Vorster M; Rodrigues HG; Zeevaart JR; Gordon S; Moura-Alves P; Sathekge MM
    Front Immunol; 2021; 12():752380. PubMed ID: 34691068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic modifications associated with genes implicated in cytokine storm: The potential biotherapeutic effects of vitamins and minerals in COVID-19.
    Muhammad A; Forcados GE; Sani H; Ndidi US; Adamu A; Katsayal BS; Sadiq IZ; Abubakar YS; Sulaiman I; Abubakar IB; Yusuf AP; Malami I; Ibrahim S; Abubakar MB
    J Food Biochem; 2022 May; 46(5):e14079. PubMed ID: 35060145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and Epigenetic Diversity of Protein Molecules Related to SARSCoV- 2 Entry: Where We Are and Where We Should Go?
    Zhu S; Chen F; Li X; Zhang Y; Wang X; Luan C
    Curr Protein Pept Sci; 2022; 23(2):70-76. PubMed ID: 35105286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents.
    Khadke S; Ahmed N; Ahmed N; Ratts R; Raju S; Gallogly M; de Lima M; Sohail MR
    Virol J; 2020 Oct; 17(1):154. PubMed ID: 33059711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.
    Kulanthaivel S; Kaliberdenko VB; Balasundaram K; Shterenshis MV; Scarpellini E; Abenavoli L
    Rev Recent Clin Trials; 2021; 16(2):138-145. PubMed ID: 32940187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic mechanisms regulating COVID-19 infection.
    Chlamydas S; Papavassiliou AG; Piperi C
    Epigenetics; 2021 Mar; 16(3):263-270. PubMed ID: 32686577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deciphering epigenetic(s) role in modulating susceptibility to and severity of COVID-19 infection and/or outcome: a systematic rapid review.
    AbdelHamid SG; Refaat AA; Benjamin AM; Elmawardy LA; Elgendy LA; Manolly MM; Elmaksoud NA; Sherif N; Hamdy NM
    Environ Sci Pollut Res Int; 2021 Oct; 28(39):54209-54221. PubMed ID: 34383213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why COVID-19 Transmission Is More Efficient and Aggressive Than Viral Transmission in Previous Coronavirus Epidemics?
    Elrashdy F; Redwan EM; Uversky VN
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32933047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted therapy strategies against SARS-CoV-2 cell entry mechanisms: A systematic review of in vitro and in vivo studies.
    Seyedpour S; Khodaei B; Loghman AH; Seyedpour N; Kisomi MF; Balibegloo M; Nezamabadi SS; Gholami B; Saghazadeh A; Rezaei N
    J Cell Physiol; 2021 Apr; 236(4):2364-2392. PubMed ID: 32901936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Covid-19: Perspectives on Innate Immune Evasion.
    Taefehshokr N; Taefehshokr S; Hemmat N; Heit B
    Front Immunol; 2020; 11():580641. PubMed ID: 33101306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis.
    Ramasamy S; Subbian S
    Clin Microbiol Rev; 2021 Jun; 34(3):. PubMed ID: 33980688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.